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Abstract
The main objective of this study was to assess the in vitro effects of curcuminoids extract,
hydrolyzed collagen and green tea extract in normal bovine chondrocytes and osteoarthritic
human chondrocytes cultured in monolayer. This study also investigated the synergic or ad-
ditive effects of these compounds. Enzymatically isolated primary bovine or human chon-
drocytes were cultured in monolayer until confluence and then incubated for 24 hours or 48
hours in the absence or in the presence of interleukin-1β and with or without curcuminoids
extract, hydrolyzed collagen or green tea extract, added alone or in combination, at different
concentrations. Cell viability was neither affected by these compounds, nor by interleukin
1β. In the absence of interleukin-1β, compounds did not significantly affect bovine chondro-
cytes metabolism. In human chondrocytes and in the absence of interleukin 1β, curcumi-
noids extract alone or in combination with hydrolyzed collagen and green tea extract
significantly inhibited matrix metalloproteinase-3 production. In interleukin-1β-stimulated
bovine chondrocytes, interleukin-6, inducible nitric oxide synthase, cyclooxygenase2, ma-
trix metalloproteinase 3, a disintegrin and metalloproteinase with thrombospondin type I mo-
tifs 4 and a disintegrin and metalloproteinase with thrombospondin type I motifs 5
expressions were decreased by curcuminoids extract alone or in combination with hydro-
lyzed collagen and green tea extract. The combination of the three compounds was signifi-
cantly more efficient to inhibit interleukin-1β stimulated matrix metalloproteinase-3
expression than curcuminoids extract alone. In interleukin-1β-stimulated human chondro-
cytes, nitric oxide, interleukin-6 and matrix metalloproteinase 3 productions were significant-
ly reduced by curcuminoids extract alone or in combination with hydrolyzed collagen and
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green tea extract. These findings indicate that a mixture of curcuminoids extract, hydrolyzed
collagen and green tea extract has beneficial effects on chondrocytes culture in inflammato-
ry conditions and provide a preclinical basis for the in vivo testing of this mixture.
Introduction
Osteoarthritis (OA) is a chronic, painful, degenerative and inflammatory condition that affects
the joints and leads to functional disability. The most prominent feature of OA is the progres-
sive degradation of articular cartilage. Chondrocytes play a key role in cartilage degradation in
OA by producing matrix metalloproteinases (MMP), free radicals and inflammatory cytokines
in response to mechanical or biochemical stimuli [1, 2]. These mediators, not only are involved
in cartilage matrix degradation but also in cross-talk with synovial and subchondral bone cells.
Nowadays, curative treatments for OA remain missing and the management of OA focuses
on the alleviation of symptoms. Current recommendations for the management of OA include
a combination of non-pharmacological and pharmacological modalities. Moreover, for pa-
tients with severe OA, joint replacement is indicated [3]. Among non-pharmacological recom-
mendations, exercise (land-based and water-based), biomechanical interventions, weight loss if
overweight or obesity, and thermal modalities are widely recommended [3–5]. The most rec-
ommended pharmacological treatments include acetaminophen/paracetamol and non-
steroidal anti-inflammatory drugs (NSAIDs) (topical or oral). Intra-articular corticosteroids
are generally recommended for hip and knee OA [3–5]. However, the long-term use of
NSAIDs and acetaminophen may be associated with detrimental effects, especially gastrointes-
tinal adverse effects [6].
In this context, safer alternative treatments are needed. Such treatments could come from
nutrition and more particularly from nutraceuticals. Some positive beneficial effects are
highlighted with nutraceuticals in the course of OA [7, 8]. Among them, curcumin, which is
the major component of turmeric, a yellow spice derived from the roots of the plant Curcuma
longa. Anti-catabolic, anti-apoptotic and anti-inflammatory effects of curcumin are largely de-
scribed in vitro. It is demonstrated that curcumin decreases nitric oxide (NO), prostaglandin
E2 (PGE2), IL-6, IL-8, cyclooxygenase2 (COX2), inducible nitric oxide synthase (iNOS), MMP-
3 and MMP-9 synthesis through the inhibition of nuclear factor κB (NF-κB) translocation and
tumor necrosis factor (TNF)-α signaling pathways in chondrocytes [9–13]. Hydrolyzed colla-
gen is obtained by the enzymatic hydrolysis of collagenous tissues, like for example, animal
bone, and is generally recognized as a safe food ingredient by regulatory agencies [14, 15]. The
main characteristic of hydrolyzed collagen is its amino acid composition, which is identical to
collagen, thus providing high levels of glycine and proline, two amino acids essential for the
stability and regeneration of cartilage [16, 17]. Proteoglycans synthesis, aggrecan gene expres-
sion and type II collagen synthesis are increased with hydrolyzed collagen in bovine and por-
cine articular chondrocytes [18, 19]. Epigallocatechin-3-gallate (EGCG) is a major component
of the polyphenolic fraction of green tea and exhibits anti-oxidant, anti-tumor and anti-
mutagenic activities [7, 20]. Advanced glycation end products (AGE)-induced expressions of
TNF-α and MMP-13 are inhibited by EGCG in human OA chondrocytes. Otherwise, AGE-
induced mitogen activated protein kinase (MAPK) signaling pathways and NF-κB activation
are inhibited in that model [21]. The expression of mediators associated with OA pathogenesis
is suppressed in human chondrocytes pre-treated with EGCG and then stimulated with IL-1β
[22]. IL-1β induced mRNA expression and protein production of MMP-1 and MMP-13 are
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inhibited in an EGCG concentration dependant manner in human chondrocytes [23]. The
transcription activity of NF-κB and the IL-1β-induced glycosaminoglycans (GAG) release
from human cartilage explants are also reduced [23].
It has been reported that the majority of the pro-inflammatory and catabolic mediators
linked to OA are regulated by NF-κB [24]. The subunits of NF-κB, p65 and p50, resides in the
cytoplasm as an inactive complex in association with an inhibiting IκBα subunit. When phos-
phorylated, IκBα dissociated from the complex, and NF-κB, in response to phosphorylation of
its subunit p65, is translocated to the nucleus, where it induces gene transcription and hence
expression of more than 400 genes some of which are intimately involved in regulating apopto-
sis, proliferation and inflammation [25].
For the first time, this paper compares the effects of curcuminoids extract (C), hydrolyzed
collagen (O) and green tea extract (T) in normal bovine and OA human chondrocytes cultured
in monolayer. Further, this study investigates the synergic or additive effects of these com-
pounds. Finally, we investigated the effects of these compounds on IL-1β induced NF-κB
signaling pathway.
Material and Methods
Origin of chondrocytes and ethics statement
Normal bovine articular cartilage was obtained from “Public slaughterhouse of Liege” from the
metacarpal/metatarsal-phalangeal joint of 1 to 2 years old steers shortly after death [11]. OA
human articular cartilage was removed from knee joints of three patients undergoing total
knee-replacement surgery [26]. All subjects provided written informed consent, and ethical ap-
proval (ethics committee agreement of Catholic University of Louvain, no. B403201111664)
was granted for this study.
Chondrocytes isolation
Full-depth articular cartilage was excised and immersed in Dulbecco’s Modified Eagle Medium
(DMEM) (with phenol red and 4.5 g/L glucose) supplemented with N-(2-hydroxyethyl)
piperazine-N’-(2-ethanesulfonic acid) (HEPES) 10 mM, penicillin (100 U/ml) and streptomy-
cin (0.1 mg/ml) (all from Lonza, Verviers, Belgium). After three washings, chondrocytes were
released from cartilage by sequential enzymatic digestions with 0.5 mg/ml hyaluronidase type
IV S (Sigma-Aldrich, Bornem, Belgium) for 30 min at 37°C, 1 mg/ml pronase E (Merck, Leu-
ven, Belgium) for 1 h at 37°C and 0.5 mg/ml clostridial collagenase IA (Sigma-Aldrich, Bor-
nem, Belgium) for 16 to 20 h at 37°C. The enzymatically isolated cells were then filtered
through a nylon mesh (70 μm), washed three times, counted and filled to the density of 0.25 x
106 cells/ml (bovine chondrocytes) or 0.1 x 106 cells/ml (human chondrocytes) of DMEM
(with phenol red and 4.5 g/L glucose) supplemented with 10% fetal bovine serum, 10 mM
HEPES, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mM glutamine (all from Lonza, Ver-
viers, Belgium) and 20 μg/ml proline (Sigma-Aldrich, Bornem, Belgium)
Chondrocytes culture
Cells were seeded in a 6-well plate at the density of 0.5 x 106 cells/well (bovine chondrocytes)
or 0.2 x 106 cells/well (human chondrocytes) and cultured in monolayer for 5 days.
Chondrocytes were then cultured in monolayer until confluence (for about 24 hours) in
DMEM (phenol red-free and containing only 1 g/L glucose) (Lonza, Verviers, Belgium) supple-
mented with 1% fetal bovine serum, 10 mMHEPES, 100 U/ml penicillin, 0.1 mg/ml streptomy-
cin, 2 mM glutamine and 20 μg/ml proline. Only primary cultures were used to ensure the
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stability of chondrocyte phenotype. When normal bovine chondrocytes achieved confluence,
the culture medium was removed and replaced by fresh culture medium containing curcumi-
noids extract (Naturex, Avignon, France) or hydrolyzed collagen (Gelita, Eberbach, Germany)
or green tea extract (Naturex, Avignon, France) at the final concentration of 0.5 μg/ml, 2.5 μg/
ml, 12.5 μg/ml or 62.5 μg/ml, with or without recombinant porcine IL-1β (10–10 M) (R&D Sys-
tem, Abingdon, UK). To investigate their potential synergic or additional effects, nutraceuticals
were then tested alone at the final concentration of 12.5 μg/ml or in combination (12.5 μg/ml
curcuminoids extract + 12.5 μg/ml hydrolyzed collagen; 12.5 μg/ml curcuminoids extract +
12.5 μg/ml green tea extract; 12.5 μg/ml curcuminoids extract + 12.5 μg/ml hydrolyzed
collagen + 12.5 μg/ml green tea extract) in the absence or in the presence of recombinant por-
cine IL-1β (10–10 M). When OA human chondrocytes achieved confluence, the culture medi-
um was removed and replaced by fresh culture medium and tested compounds alone or in
combination (1–2–4 μg/ml curcuminoids extract + 1–2–4 μg/ml hydrolyzed collagen + 1–2–
4 μg/ml green tea extract), at concentrations ranging between 1 to 4 μg/ml, and in the absence
or in the presence of human IL-1β (10–11 M) (R&D System, Abingdon, UK). To investigate the
effects of compounds on IL-1β induced NF-κB signaling pathway, OA human chondrocytes
were pre-incubated with 4 μg/ml curcuminoids extract or with the combination 4 μg/ml curcu-
minoids extract + 4 μg/ml hydrolyzed collagen + 4 μg/ml green tea extract for 24 h and then
co-treated with IL-1β (10–11 M) for 5 or 15 minutes or untreated. Curcuma extract is an oleo-
resin and is obtained from the roots of the plant Curcuma longa. Curcuminoids extract from
Naturex is composed of natural extract and methylcellulose, and its content in curcuminoids is
about 82% of which 75% are curcumin, 21% are demethoxycurcumin and 4% are bisdemethox-
ycurcumin. Hydrolyzed collagen from Gelita is a mix of different peptides. In average the pep-
tides are composed by 30 amino acids, meaning a molecular weight of about 3 kDa. Glycine
and proline represent more than 35% of total amino acids content. Green tea extract from Nat-
urex, obtained from green tea leaves, contained natural extract and maltodextrin. Total poly-
phenols content is higher than 25%, catechins content higher than 12.5% and EGCG content
higher than 9.3%. Curcuma extract was solubilized in tetrahydrofuran (Merck, Leuven, Bel-
gium). Tetrahydrofuran was added in each condition to obtain final concentration at 0.1%. Hy-
drolyzed collagen and green tea extract were dissolved in water and filtered through a sterile
mesh (0.20 μm). The effects of compounds were compared to controls consisting in same
media without compounds and with or without IL-1β. Each culture condition was tested in
triplicate in three independent chondrocytes cultures. Chondrocytes were incubated for 24 or
48 hours with the compounds and/or IL-1β. After 24 h of incubation, cells were scrapped, and
RNA extraction was performed using RNeasy mini kit (Qiagen, Venlo, Netherlands) for quan-
titative real time polymerase chain reaction using the LightCycler 480 (Roche, Vilvoorde,
Belgium).
After 48 h of incubation, conditioned culture media were collected for lactate dehydroge-
nase (LDH) release assay and then stored at-20°C until additional analysis. Cells were scrapped
and homogenized in 500 μl of Tris-HCl buffer by ultrasonic dissociation for 20 s at 4°C, to
measure desoxyribonucleic acid (DNA) content.
Lactate dehydrogenase release assay
Cell viability was estimated by quantifying the release of LDH in the culture supernatant as pre-
viously described [12]. A sample of the supernatant or dilutions of standard solution (LDH
from rabbit muscle) was mixed with Tris buffer (10 mM Tris-HCl (pH 8.5), 0.1% bovine serum
albumin) containing 800 mM lactate. Then, colorimetric reagent, 1.6 mg/ml iodonitrotetrazo-
lium chloride (Sigma-Aldrich, Bornem, Belgium), 4 mg/ml nicotinamide adenine dinucleotide
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(Roche Diagnostics, Brussels, Belgium), and 0.4 mg/ml phenazine methosulfate (Sigma-
Aldrich, Bornem, Belgium), was added, and the absorbance at 492 nm was read after 10 min of
incubation at room temperature.
DNA assay
DNA content was measured in the cell extracts by a fluorimetric method using Hoechst [27].
Quantitative real-time reverse transcriptase polymerase chain reaction
(RT PCR)
RNA from bovine chondrocytes from 3 wells of each condition was isolated using RNeasy mini
kit (Qiagen, Venlo, Netherlands). Then, RNA was reverse transcribed. Quantitative real time
Polymerase Chain Reaction (qPCR) was performed by using the SYBR Premix Ex Taq (Tli
RNaseH Plus) (Westburg, Leusden, Netherlands) as previously described [28]. The PCR tem-
plate source was either first-strand complementary DNA (cDNA) (samples) or purified DNA
standard (standard curve). Forward and reverse bovine primer sequences used to amplify the
desired cDNA are presented in Table 1. Amplification was performed with a spectrofluoromet-
ric thermal cycler (LightCycler 480, Roche Diagnostics, Vilvoorde, Belgium). To standardize
mRNA levels, we amplified hypoxanthine phosphoribosyltransferase (HPRT), a housekeeping
gene, as an internal control. Gene expression was normalized by calculating the ratio between
the number of cDNA copies of IL-6, COX2, iNOS, MMP-3, a disintegrin and metalloproteinase
with thrombospondin motifs (ADAMTS) 4, and 5, and that of HPRT.
Nitrite assay
Nitric oxide (NO) production was determined by quantifying its derived product, nitrite, in the
culture supernatant using a spectrophotometric method based upon the Griess reaction, as pre-
viously described [12]. Briefly, a sample of the supernatant or sodium nitrite (NaNO2) standard
dilutions was mixed with Griess reagent (0.5% sulphanilamide, 0.05% naphtyl ethylene di-
amine dihydrochloride, 2.5% H3PO4). The absorption was measured at 540 nm.
Prostaglandin E2 assay
PGE2 production was measured in the culture supernatant using the DetectX PGE2 High Sensi-
tivity Immunoassay kit (Arbor Assays, Michigan, USA). Briefly, 100 μl of the supernatant or
PGE2 standard dilutions were pipetted into a clear microtiter plate coated with an antibody to
Table 1. Sequences of forward and reverse bovine primers used for PCR.
Gene Forward bovine primer Reverse bovine primer
HPRT 5’-AGTTTGGAAATACCTGGCG-3’ 5’-AGTCTTTAGGCTCGTAGTGC-3’
IL-6 5’- TGGTGATGACTTCTGCTTTCC-3’ 5’- TGCCAGTGTCTCCTTGC-3’
COX2 5’-GTCTGATGATGTATGCCACC-3’ 5’-ACGTAGTCTTCAATCACAATCT-3’
iNOS 5’- GGCAAGCACCACATTGAGA-3’ 5’- TGCGGCTGGATTTCGGA-3’
MMP-3 5’-TCTATGAAGGAGAAGCTGACATAAT-3’ 5’-TTCATGGGCAGCAACAAG-3’
ADAMTS 4 5’- CTTTCAATGTCCCACAGGC-3’ 5’- CAGGAACGGAAGCGGGTA-3’
ADAMTS 5 5’- GACACCCTGGGAATGGCA-3’ 5’- CACAGAACTTGGAATCGTCA-3’
HPRT = hypoxanthine phosphoribosyltransferase, IL-6 = interleukin-6, COX2 = cyclooxygenase2, iNOS = inducible nitric oxide synthase, MMP-3 = matrix
metalloproteinase-3, ADAMTS4 = a disintegrin and metalloproteinase with thrombospondin type I motifs 4, ADAMTS5 = a disintegrin and
metalloproteinase with thrombospondin type I motifs 5.
doi:10.1371/journal.pone.0121654.t001
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capture mouse IgG. A PGE2-peroxidase conjugate (25 μl) is added to the standards and super-
natants in the wells. The binding reaction was initiated by the addition of 25 μl of a monoclonal
antibody to PGE2. After an overnight incubation at 4°C, the plate was washed and 100 μl of
substrate was added. After a short incubation, the reaction was stopped and the intensity of the
generated colour was detected at 450 nm wavelength.
Immunoassays for interleukin-6, matrix metalloproteinase-3 and
aggrecans
IL-6, MMP-3, and aggrecans were measured by specific enzyme amplified sensitivity immuno-
assays (Invitrogen, Merelbeke, Belgium). IL-6 and MMP-3 productions were measured in cul-
ture supernatants, whereas aggrecans production was measured in culture supernatants and in
the cell extracts.
Western blotting
Cells were collected at 4°C and lysed on ice in 50 μl of buffer (25 mMHepes, 150 mMNaCl,
0.5% Triton X-100, 10% glycerol, and 1 mM dithiothreitol) containing protease and phospha-
tase inhibitors (Roche, Vilvoorde, Belgium). After incubation at 4°C for 30 minutes, lysates
were then centrifugated at 14,000 g for 30 minutes at 4°C to remove insoluble debris. Protein
concentrations were determined using the BCA assay (Thermo Fisher Scientific, Erembode-
gem, Belgium). Total protein extracts (20 μg) were fractioned by electrophoresis on a polyacryl-
amide gel (10%) and transferred onto a PVDF membrane. Membranes were blocked for 1 h in
TBS-Tween containing 5% nonfat dried milk (HSC70) or in 2% bovine serum albumin
(phospho-NF-κB p65 and phospho-IκBα). Membranes were then incubated overnight at 4°C
with primary antibodies. Anti-rabbit phospho-NF-κB p65 (1:1000 dilution), anti-rabbit phos-
pho-IκBα (1:1000 dilution) and anti-rabbit HSC70 (1:1000 dilution) (Cell signaling, Boston,
USA) were used. Horse-radish peroxidase (HRP)-linked anti-rabbit IgG antibody (1:2000 dilu-
tion) was used as secondary antibody (Cell signaling, Boston, USA). The reaction was revealed
with the ECLWestern blotting substrate (Thermo Fisher Scientific, Erembodegem, Belgium).
Statistical analysis
Results were normalized to the HPRT gene expression or to the DNA content of the cells and
expressed as the mean ± SEM or reported to the control and expressed in percent. Statistical
significance is assessed using a parametric one-way ANOVA, followed by Dunnett’s multiple
comparison post-test for statistical significance compared to control, and followed by Tukey’s
multiple comparison post-test for statistical significance compared to the mixture. Differences
were considered statistically significant at p-value< 0.05.
Results
Effects of curcuminoids extract, hydrolyzed collagen and green tea
extract on normal bovine chondrocytes in monolayer
Bovine chondrocytes were cultured for 24 hours (gene expressions analysis) or 48 hours (pro-
tein productions analysis) in the absence or in the presence of IL-1β and with or without curcu-
minoids extract (C), hydrolyzed collagen (O) or green tea extract (T) added alone or in
combination (COT). Cell viability, evaluated by LDH release, and DNA content, was not sig-
nificantly modified by compounds alone or in combination, with or without IL-1β (data not
shown).
Nutraceuticals Inhibit Inflammation and Catabolism
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In basal conditions, NO and PGE2 productions were undetectable. However, bovine chon-
drocytes expressed 0.43 ± 0.23 copies of IL-6 mRNA, 7.83 ± 2.83 copies of iNOS mRNA,
1.62 ± 0.93 copies of COX2 mRNA, 3.00 ± 1.00 copies of MMP-3 mRNA, 0.6 ± 0.4 copies of
ADAMTS4 mRNA, 13.13 ± 2.64 copies of ADAMTS5 mRNA and 146.9 ± 82.51 copies of
aggrecans mRNA per copy of HPRT. The compounds did not significantly affect the basal ex-
pression of these genes.
In the presence of IL-1β, the productions of NO and PGE2 were 5.16 ± 1.42 nmol/μg DNA
and 8,372.95 ± 5,187.35 pg/μg DNA, respectively. IL-1β increased the expression of the genes
coding for IL-6, iNOS, COX2, MMP-3, ADAMTS4, ADAMTS5 by 178.16 ± 8.04, 17.87 ± 7.72,
11.18 ± 2.48, 88.41 ± 45.19, 25.67 ± 14.73, 3.26 ± 1.03-fold, respectively and decreased aggre-
cans by 7.00 ± 3.32-fold. In the presence of IL-1β and at the concentrations of 12.5 and 62.5 μg/
ml, C significantly and fully inhibited NO production (p = 0.0101), while O and T were without
effects (Fig. 1a). At the concentrations of 2.5, 12.5 and 62.5 μg/ml, C significantly inhibited
IL-1β stimulated PGE2 production (IL-1β: 8,372.95 ± 5,187.35 pg/μg DNA; 2.5 μg/ml:
1,753.93 ± 878.64 pg/μg DNA, p = 0.0478; 12.5 μg/ml: 9.19 ± 9.19 pg/μg DNA, p = 0.0076 and
62.5 μg/ml: 9.31 ± 9.31 pg/μg DNA, p = 0.0076) (Fig. 1b). In contrast, O and T had no signifi-
cant effect on PGE2 production.
In the presence of IL-1β and at the concentrations of 12.5 and 62.5 μg/ml, C significantly in-
hibited IL-6 (IL-1β: 100.23 ± 18.99 copies mRNa per copy of HPRT; 12.5 μg/ml: 3.67 ± 2.52
copies mRNA per copy of HPRT, p<0.0001; 62.5 μg/ml: 2.37 ± 1.28 copies mRNA per copy of
HPRT, p<0.0001), COX2 (IL-1β: 13.93 ± 4.52 copies mRNA per copy of HPRT; 12.5 μg/ml:
4.79 ± 2.77 copies mRNA per copy of HPRT, p<0.0001; 62.5 μg/ml: 5.01 ± 2.9 copies mRNA
per copy of HPRT, p = 0.0001) iNOS (IL-1β: 99.43 ± 1.59 copies mRNA per copy of HPRT;
12.5 μg/ml: 5.33 ± 3.26 copies mRNA per copy of HPRT, p<0.0001; 62.5 μg/ml: 5.33 ± 1.41
copies mRNA per copy of HPRT p<0.0001), MMP-3 (IL-1β: 220.05 ± 38.5 copies mRNA per
copy of HPRT; 12.5 μg/ml: 18.25 ± 8.86 copies mRNA per copy of HPRT, p<0.0001; 62.5 μg/
ml: 9.1 ± 2.2 copies mRNA per copy of HPRT, p<0.0001), ADAMTS4 (IL-1β: 7.53 ± 2.24 cop-
ies mRNA per copy of HPRT; 12.5 μg/ml: 1.47 ± 0.75 copies mRNA per copy of HPRT,
p = 0.0005; 62.5 μg/ml: 1.5 ± 0.85 copies mRNA per copy of HPRT, p = 0.0008) and ADAMTS5
(IL-1β: 37.67 ± 4.39 copies mRNA per copy of HPRT; 12.5 μg/ml: 11.87 ± 3.42 copies mRNA
per copy of HPRT, p = 0.0073; 62.5 μg/ml: 9.77 ± 3.01 copies mRNA per copy of HPRT,
p = 0.0037) gene expressions (Fig. 2a, b, c, d, e, f). In the presence of IL-1β and at the concentra-
tion of 62.5 μg/ml, T significantly inhibited IL-6 (IL-1β: 100.23 ± 18.99 copies mRNA per copy
of HPRT; 62.5 μg/ml: 35.6 ± 4.92 copies mRNA per copy of HPRT, p = 0.0309) and COX2 (IL-
1β: 13.93 ± 4.52 copies mRNA per copy of HPRT; 62.5 μg/ml: 9 ± 4.69 copies mRNA per copy
of HPRT, p = 0.0311) gene expressions (Fig. 2a, b). In the presence of IL-1β and at the concen-
tration of 12.5 μg/ml, O significantly increased MMP-3 gene expression (IL-1β: 220.05 ± 38.5
copies mRNA per copy of HPRT; 12.5 μg/ml: 337.35 ± 67.81 copies mRNA per copy of HPRT,
p = 0.0063) (Fig. 2d).
We have also tested two compounds in combination, CO and CT. CO and CT tended to be
more efficient than C on all parameters. The differences between C and CO groups were not
statistically significant. In contrast, CT reduced higher IL-1β-stimulated MMP-3 expression
than C (p = 0.0386) (Table 2).
The mixture COT significantly inhibited IL-1β stimulated NO and PGE2 productions
(p<0.0001), but the inhibitory effect was not higher than C alone (Fig. 3). The magnitude of
COT inhibitory effect was higher than C alone on IL-1β-stimulated IL-6 mRNA (52.73 ± 15.64
copies mRNA per copy of HPRT for C vs 5.07 ± 4.32 copies mRNA per copy of HPRT for
COT, p<0.0001), COX2 mRNA (6.2 ± 2.04 copies mRNA per copy of HPRT for C vs
1.07 ± 0.38 copies mRNA per copy of HPRT for COT, p = 0.0035), iNOS mRNA (11.27 ± 5.04
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copies mRNA per copy of HPRT for C vs 3.5 ± 2.41 copies mRNA per copy of HPRT for COT,
p<0.0001) (Fig.4a), MMP-3 mRNA (85.8 ± 44.88 copies mRNA per copy of HPRT for C vs
1.87 ± 0.93 copies mRNA per copy of HPRT for COT, p<0.0001), ADAMTS4 mRNA
(4.47 ± 2.09 copies mRNA per copy of HPRT for C vs 1.23 ± 0.48 copies mRNA per copy of
HPRT for COT, p = 0.003) and ADAMTS5 mRNA (50.57 ± 1.62 copies mRNA per copy of
Fig 1. Compounds effects on IL-1β stimulated bovine chondrocytes in monolayer (production).
Results were expressed as percent of IL-1β treated chondrocytes culture (control). *p<0.05 versus control,
**p<0.01 versus control. (a) NO = nitric oxide, (b) PGE2 = prostaglandin E2.
doi:10.1371/journal.pone.0121654.g001
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Fig 2. Compounds effects on IL-1β stimulated bovine chondrocytes in monolayer (expression).
Results were expressed as percent of IL-1β treated chondrocytes culture (control). *p<0.05 versus control,
**p<0.01 versus control, ***p<0.001 versus control. (a) IL-6 = interleukin-6, (b) COX2 = cyclooxygenase2,
(c) iNOS = inducible nitric oxide synthase, (d) MMP-3 = matrix metalloproteinase-3, (e) ADAMTS4 = a
disintegrin and metalloproteinase with thrombospondin type 1 motifs 4 and (f) ADAMTS5 = a disintegrin and
metalloproteinase with thrombospondin type 1 motifs 5.
doi:10.1371/journal.pone.0121654.g002
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HPRT for C vs 29.67 ± 4.68 copies mRNA per copy of HPRT for COT, p = 0.0248) (Fig. 4b)
gene expressions.
Effects of curcuminoids, hydrolyzed collagen and green tea extract on
OA human chondrocytes in monolayer
Primary OA human chondrocytes were cultured in monolayer until confluence and then incu-
bated for 48 hours in the absence or in the presence of IL-1β and with or without C, O or T
added alone or in combination (COT). Cell viability, evaluated by LDH release, and DNA con-
tent, was not affected by these compounds added alone or in combination, with or without IL-
1β (data not shown).
In basal conditions, NO production was undetectable while the content of IL-6, MMP-3
and aggrecans in culture supernatants were 232.32 ± 85.3 pg/μg DNA, 207.34 ± 15.83 ng/μg
DNA and 538 ± 86.48 ng/μg DNA, respectively. The aggrecans content in chondrocytes extract
was 28.92 ± 4.61 ng/μg DNA. In basal conditions, MMP-3 production was significantly inhib-
ited by C at 2 (151.86 ± 19.03 ng/μg DNA, p = 0.0166) and 4 μg/ml (92.84 ± 19.49 ng/μg DNA,
p<0.0001) (Fig. 5a). At the concentration of 4 μg/ml, C significantly decreased the aggrecans
Table 2. Compounds effects on IL-1β stimulated bovine chondrocytes in monolayer.
C CO CT
Production NO % of ctrl 3,84 0,000001 0,000001
p-value vs ctrl <0,0001 <0,0001 <0,0001
p-value vs C 0,9996 0,9996
PGE2 % of ctrl 0,9323 0,4982 0,000001
p-value vs ctrl 0,9925 0,9924 0,9922
p-value vs C >0,9999 >0,9999
Gene expression IL-6 % of ctrl 16,37 10,93 0,47
p-value vs ctrl <0,0001 <0,0001 <0,0001
p-value vs C 0,9988 0,7944
COX2 % of ctrl 48,72 42,36 13,28
p-value vs ctrl 0,0719 0,0385 0,0021
p-value vs C 0,9998 0,524
iNOS % of ctrl 14,18 8,671 3,757
p-value vs ctrl <0,0001 <0,0001 <0,0001
p-value vs C 0,9879 0,8005
MMP-3 % of ctrl 42,5 15,41 1,21
p-value vs ctrl 0,0011 <0,0001 <0,0001
p-value vs C 0,2934 0,0386
ADAMTS4 % of ctrl 45,28 31,81 17,16
p-value vs ctrl 0,0279 0,0061 0,0012
p-value vs C 0,9818 0,6516
ADAMTS5 % of ctrl 53,33 48,02 24,32
p-value vs ctrl 0,1905 0,1261 0,0168
p-value vs C >0,9999 0,8233
Ctrl = IL-1β stimulated bovine chondrocytes, C = curcuminoids extract, CO = curcuminoids extract + hydrolyzed collagen, CT = curcuminoids extract +
green tea extract, NO = nitric oxide, PGE2 = prostaglandin E2, IL-6 = interleukin-6, COX2 = cyclooxygenase-2, iNOS = inducible nitric oxide synthase,
MMP-3 = matrix metalloproteinase-3, ADAMTS4 = a disintegrin and metalloproteinase with thrombospondin type I motifs 4, ADAMTS5 = a disintegrin and
metalloproteinase with thrombospondin type I motifs 5.
doi:10.1371/journal.pone.0121654.t002
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content in culture supernatants (214.87 ± 41.34 ng/μg DNA, p = 0.0232) (Fig. 5b), but had no
effect on aggrecans content in chondrocytes extract (Fig. 5c). None of the compounds, neither
the combination, showed significant effects on NO and IL-6 productions in the absence of IL-
1β on human chondrocytes (data not shown). O and T had no significant effect on human
chondrocytes in basal conditions.
In basal conditions, MMP-3 production was significantly inhibited by the COT mixture at
1:1:1 (139.1 ± 30.13 ng/μg DNA, p = 0.0105), 2:2:2 (110.95 ± 20.97 ng/μg DNA, p<0.0001) and
4:4:4 μg/ml (78.03 ± 14.85 ng/μg DNA, p<0.0001) (Fig. 5a). At the concentration of 1:1:1 μg/
ml, COT inhibited MMP-3 production while C, O or T individually had no effect. This indicat-
ed that, at the concentration of 1 μg/ml, C, O and T acted in synergy on this parameter. Fur-
ther, COT at 4:4:4 μg/ml significantly decreased the aggrecans content in culture supernatants
(192.91 ± 45.98 ng/μg DNA, p = 0.0133) (Fig. 5b), but had no significant effect on aggrecans
content in chondrocytes extract (Fig. 5c). However, COT had a similar effect on the aggrecans
in culture supernatants than C.
In the presence of 10–11 M IL-1β, the production of NO was 37.92 ± 6.04 nmol/μg DNA. IL-
1β significantly increased the production of IL-6 and MMP-3 by 2,114.91 ± 789.59 and
13.61 ± 2.7-fold, respectively. In contrast, IL-1β inhibited aggrecans content in cells extract and
supernatants by 1.37 ± 0.36 and 4.72 ± 1.83-fold, respectively. C significantly inhibited IL-1β
stimulated NO production at the concentration of 4 μg/ml (IL-1β: 37.92 ± 6.04 nmol/μg
Fig 3. Compounds effects, separately or in combination, on IL-1β stimulated bovine chondrocytes in monolayer (production). Results were
expressed as percent of IL-1β treated chondrocytes culture (control). ***p<0.001 versus control, ###p<0.001 versus COT. NO = nitric oxide, PGE2 =
prostaglandin E2.
doi:10.1371/journal.pone.0121654.g003
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DNA; 4 μg/ml: 2.75 ± 2.75 nmol/μg DNA, p<0.0001) (Fig. 6a), IL-1β stimulated IL-6 produc-
tion at the concentrations of 2 (IL-1β: 374,153.98 ± 55,870.58 pg/μg DNA; 2 μg/ml:
198,865.78 ± 51,036.33 pg/μg DNA, p = 0.0029) and 4 μg/ml (IL-1β: 374,153.98 ± 55,870.58
pg/μg DNA; 4 μg/ml: 26,185.84 ± 9,712.2 pg/μg DNA, p<0.0001) (Fig. 6b) and IL-1β stimulat-
ed MMP-3 production at the concentration of 4 μg/ml (IL-1β: 2,839.88 ± 661.96 ng/μg DNA;
Fig 4. Compounds effects, separately or in combination, on IL-1β stimulated bovine chondrocytes in monolayer (expression).Results were
expressed as percent of IL-1β treated chondrocytes culture (control). *p<0.05 versus control, **p<0.01 versus control, ***p<0.001 versus control,
#p<0.05 versus COT, ##p<0.01 versus COT, ###p<0.001 versus COT. (a) IL-6 = interleukin-6, COX2 = cyclooxygenase2, iNOS = inducible nitric oxide
synthase, (b) MMP-3 = matrix metalloproteinase-3, ADAMTS4 = a disintegrin and metalloproteinase with thrombospondin type 1 motifs 4 and ADAMTS5 = a
disintegrin and metalloproteinase with thrombospondin type 1 motifs 5.
doi:10.1371/journal.pone.0121654.g004
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4 μg/ml: 946.97 ± 254.48 ng/μg DNA, p = 0.024) (Fig. 6c). O significantly inhibited IL-1β stim-
ulated NO production at the concentration of 2 μg/ml (IL-1β: 37.92 ± 6.04 nmol/μg DNA;
2 μg/ml: 24.87 ± 2.96 nmol/μg DNA, p = 0.0394) (Fig. 6a) but had no significant effect on the
other parameters. T alone had no significant effect on IL-1β treated human chondrocytes.
Fig 5. Compounds effects, separately or in combination, on human chondrocytes in monolayer
(production). Results were expressed as percent of control. *p<0.05 versus control, ***p<0.001 versus
control, #p<0.05 versus COT, ###p<0.001 versus COT. (a) MMP-3 = matrix metalloproteinase-3,
(b, c) aggrecans.
doi:10.1371/journal.pone.0121654.g005
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The COT mixture significantly decreased IL-1β-stimulated NO production at the concen-
trations of 2:2:2 (IL-1β: 37.92 ± 6.04 nmol/μg DNA; 2:2:2 μg/ml: 17.74 ± 4.72 nmol/μg DNA,
p = 0.0003) and 4:4:4 μg/ml (IL-1β: 37.92 ± 6.04 nmol/μg DNA; 4:4:4 μg/ml: 1.65 ± 1.15 nmol/
μg DNA, p<0.0001) (Fig. 6a). At the concentration of 4:4:4 μg/ml, COT and C effects on NO
Fig 6. Compounds effects, separately or in combination, on IL-1β stimulated human chondrocytes in
monolayer (production). Results were expressed as percent of IL-1β treated chondrocytes culture (control).
*p<0.05 versus control, **p<0.01 versus control, ***p<0.001 versus control, #p<0.05 versus COT,
##p<0.01 versus COT, ###p<0.001 versus COT. (a) NO = nitric oxide, (b) IL-6 = interleukin-6,
(c) MMP-3 = matrix metalloproteinase-3.
doi:10.1371/journal.pone.0121654.g006
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were not significantly different whereas, at the concentration of 2:2:2 μg/ml, COT had a higher
inhibitory effect than O (Fig. 6a). The COT mixture significantly decreased IL-1β stimulated
IL-6 production at the concentrations of 1:1:1 (IL-1β: 374,153.98 ± 55,870.58 pg/μg DNA;
1:1:1 μg/ml: 238,658.42 ± 61,332.79 pg/μg DNA, p = 0.0259), 2:2:2 (IL-1β: 374,153.98 ±
55,870.58 pg/μg DNA; 2:2:2 μg/ml: 165,110.45 ± 22,791.39 pg/μg DNA, p = 0.0006) and
4:4:4 μg/ml (IL-1β: 374,153.98 ± 55,870.58 pg/μg DNA; 4:4:4 μg/ml: 28,127.75 ± 6,569.56 pg/μg
DNA, p<0.0001) (Fig. 6b). C, O and T added separately at the concentration of 1 μg/ml had no
effect on IL-6 production. In contrast, COT mixture (1:1:1 μg/ml) significantly reduced IL-1β
stimulated IL-6 production (p = 0.0259). However, at the concentrations of 2:2:2 and
4:4:4 μg/ml, there was no additive effect of COT on IL-1β stimulated IL-6 production, com-
pared to C (Fig. 6b). The COT mixture, at 4:4:4 μg/ml, decreased IL-1β stimulated MMP-3 pro-
duction (IL-1β: 2,839.88 ± 661.96 ng/μg DNA; 4:4:4 μg/ml: 863.56 ± 181.07 ng/μg DNA,
p = 0.0119) but this inhibitory effect was similar to that of C (Fig. 6c).
We next investigated the effects of C and COT on human chondrocytes on IL-1β induced
NF-κB activation. Protein extracts of chondrocytes were probed for the phosphorylated p65
NF-κB subunit after pre-treatment with C or COT for 24 h followed by co-treatment or not
with IL-1β (10–11 M) for 5 or 15 minutes. C and COT inhibited IL-1β induced phosphorylation
and translocation of p65 in nuclear extracts of chondrocytes (Fig. 7). Further, to examine
whether inhibition of IL-1β induced NF-κB activation occurred through inhibition of IκBα
degradation, protein extracts of chondrocytes were probed for the phosphorylated IκBα sub-
unit after pre-treatment with C or COT for 24 h followed by co-treatment or not with IL-1β
(10–11 M) for 5 or 15 minutes. IL-1β induced IκBα degradation as early as 5 min, but IL-1β
could not induce IκBα subunit degradation in C and COT pre-treated chondrocytes (Fig. 7).
Discussion
This study aimed 1) to compare the effects of three nutraceuticals, curcuminoids extract, hy-
drolyzed collagen and green tea extract on chondrocytes metabolism, 2) to investigate a poten-
tial synergic effect between these compounds and 3) to examine whether the effects of
curcuminoids extract and the combination of the three compounds on human chondrocytes
involved the NF-κB signaling pathway. Numerous mediators contribute to both degradative
and nociceptive pathways associated with the progression of OA [29]. Among these mediators,
some cytokines like IL-1β play a key role in OA, by stimulating cartilage degradation and by
triggering synovial membrane inflammation [30]. In vitro, IL-1β strongly stimulates cartilage
degradation, and inhibits proteoglycan and collagen synthesis [2, 31–33]. IL-1β increases the
production of a large spectrum of proteolytic enzymes such as ADAMTS4, ADAMTS5, MMP-
3 and a variety of other cytokines, including IL-6 and IL-8, by chondrocytes. For these reasons,
we treated human primary chondrocytes with IL-1β to mimic OA chondrocyte metabolic re-
sponses. Normalizing chondrocyte metabolism and, more particularly, counteracting the dele-
terious effects of IL-1β, are targets for pharmaceutical agents in OA. Evidence to date indicates
that in addition to IL-1β, IL-6 and IL-8 can also promote articular cartilage extracellular matrix
degradation or synergize with other cytokines to amplify and accelerate cartilage destruction
[29, 33]. As expected, IL-1β stimulation of chondrocytes significantly induced the expression
of COX2, iNOS, ADAMTS4 and ADAMTS5 and the production of NO and PGE2 in our ex-
periments. Moreover, IL-1β treatment significantly induced the mRNA expression as well as
protein production of IL-6 and MMP-3, and significantly reduced the mRNA expression as
well as protein production of aggrecans by chondrocytes.
We have demonstrated that C had beneficial effects on chondrocytes. In fact, C counter-
acted the deleterious effects of IL-1β on chondrocytes. More precisely, C reduced the
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stimulating effect of IL-1β on pro-inflammatory and pro-catabolic mediators like cytokines,
NO or MMP. These effects were mediated by inhibiting NF-kB signaling pathway. C inhibited
IL-1β induced activation of NF-κB and its translocation to the chondrocyte nucleus. Further, C
abolished IL-1β induced degradation of IκBα subunit. Our results were consistent with previ-
ously published results showing that curcumin suppressed IL-1β induced NF-κB activation via
inhibition of IκBα phosphorylation and p65 phosphorylation [10], and prevented nuclear
translocation of NF-κB [9].
These data confirm those of previous studies demonstrating that purified curcumin inhib-
ited IL-1β stimulated NO, PGE2 and MMP-3 productions, and IL-1β stimulated IL-6 and IL-8
gene expressions in primary bovine normal chondrocytes and human OA chondrocytes
[11, 12], by inhibiting the phosphorylation of Iκβα [34]. In addition, we demonstrated that C
significantly inhibited gene expressions of ADAMTS4 and ADAMTS5, two enzymes directly
involved in aggrecans cleavage. We also observed that C reduced aggrecan content in the cul-
ture supernatant without affecting significantly aggrecan content in cells extract. This decrease
of aggrecan in culture supernatant could result of a reduction of aggrecan synthesis or of an in-
crease of aggrecan degradation as antibodies used in the aggrecan immunoassay target the hy-
aluronic acid binding region or keratan sulfates residues. Therefore, an increase of aggrecan
degradation reduces the amount of aggrecan measured in culture supernatant. However, we
failed to show that C increased ADAMTS gene expression or reduced aggrecan gene
Fig 7. Compounds effects on IL-1β induced phosphorylations of NF-κB p65 and IκBα subunits.Western blot analysis with IL-1β stimulated
chondrocytes total protein extracts. Chondrocytes were pre-incubated with C or COT for 24 h and then co-treated with IL-1β (10–11 M) for 5 or 15 min. The
protein extracts were probed for phospho NF-κB p65, phospho IκBα and HSC70 (control) by Western blot analysis using specific antibodies.
doi:10.1371/journal.pone.0121654.g007
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expression. The monolayer culture model is not the best model to investigate aggrecan produc-
tion and accumulation in the extracellular matrix. To verify our hypothesis, it would be inter-
esting to test C in chondrocytes cultured in alginate beads. More surprisingly were the few
effects of T and O. T significantly decreased IL-6 and COX-2 gene expressions but had no sig-
nificant effects on the other parameters while O had no significant effect. This observation con-
trasts with the results of other studies suggesting that O and T could have beneficial effects on
cartilage. Indeed, it was demonstrated that Proline-Hydroxyproline (Pro-Hyp), the major
hydroxyproline-containing peptide in human blood after oral ingestion of collagen hydroly-
sates [17], increased the aggrecan mRNA levels in murine chondrocytes [35] and collagen hy-
drolysates and Pro-Hyp inhibited murine chondrocyte differentiation into mineralized
chondrocytes and increased glycosaminoglycans production [35]. EGCG, the most abundant
catechin in green tea, suppressed the inflammatory response in human chondrocytes [22].
Other data proved that EGCG decreased the production of TNFα [21]. These discrepancies
can be explained by the cell type. Indeed, the beneficial effects of hydrolyzed collagen were ob-
served on a murine chondrocytic cell line whereas our research was performed on primary bo-
vine and human chondrocytes. Moreover, the effects of hydrolyzed collagen may differ
according the origin and formulation of collagen hydrolysates [15]. Furthermore, to show a de-
crease in inflammatory response, primary human chondrocytes were pre-treated with different
doses of EGCG for 1 or 2 hours prior to stimulation (with advanced glycation end products
[21] or with 5000 pg/ml IL-1β) while we co-treated our primary human chondrocytes with T
and with IL-1β at a lower concentration (170 pg/ml = 10–11 M) for 48 hours. It was already
shown that EGCG individually marginally inhibit COX-2 expression and PGE2 production in
cytokine-activated equine chondrocytes. Finally, EGCG, in combination with avocado and
soya unsaponifiables, reduced COX2 expression close to non-activated control levels and sig-
nificantly inhibit PGE2 production [36].
For the first time, this paper described the effects of C, O and T in combination on chondro-
cyte metabolism. In bovine chondrocytes, the three compounds showed additive inhibitory ef-
fects on IL-1β stimulated IL-6, iNOS and ADAMTS4 gene expressions. Moreover, the three
compounds acted synergically to inhibit IL-1β stimulated COX2, MMP-3 and ADAMTS5 gene
expressions. COT showed a higher effect on these parameters than C alone. Further, the inhibi-
tory effect of COT on IL-1β-induced COX-2, iNOS, MMP-3 and ADAMTS4 expressions
tended to be greater than that of CO or CT. In human chondrocytes, COT had an additive in-
hibitory effect on MMP-3 and IL-1β stimulated NO production and acted synergically on IL-
1β stimulated IL-6 production.
Altogether, these data gave a rationale for combining these compounds in the management
of OA.
One major limitation of our study is that compounds have been tested on a limited number
of cartilage specimens. Additional experiments are needed, for example in order to reach the
significance of the effects and identify the best responders among a large panel of specimens.
Of course, before recommending these natural products in the management of OA, some
clinical trials are required to demonstrate the beneficial effects of these nutraceuticals on OA
symptoms and structural changes. Another major concern is the absence of information about
dietary supplements bioavailability. This point is particularly true for polyphenol like curcu-
min. In fact, natural curcumin is known for its very low bioavailability. This point is crucial to
envisage its administration by oral route. For example, the average peak serum concentrations
after oral intake of 4, 6 and 8 g of curcumin per day were 0.51 ± 0.11, 0.63 ± 0.06 and
1.77 ± 1.87 μM, respectively [37]. The serum concentration of curcumin peaked at 1–2 h after
oral intake of curcumin and gradually declined within 12 hours. Urinary excretion of curcumin
was undetectable [37]. This mean that the concentrations of curcuminoids extract tested in this
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in vitro study (4 μg/ml ~ 10 μM) are superior to those found in plasma after oral administration
of high doses of natural curcumin. Therefore, the extrapolation of our in vitro data to human
nutrition must be done with caution. However, many effort have been made to increase curcu-
min bioavaibility. Recently, we performed a Phase I pharmacokinetics study on Flexofytol, a
high bioavailable turmeric extract with a water solubility increased 4000 times, that was run on
2 groups of 12 healthy individuals. Each group received orally 1 (42 mg curcumin) or 2 cap-
sules (84 mg of curcumin) of Flexofytol respectively. With 2 capsules administered orally, the
mean of Cmax on 12 individuals was 0.9 μM, with a statistical extrapolation at 1.6 μMwith 4
capsules (administering 84 mg and 168 mg of curcumin respectively). These values are closer
with those used in our in vitro study.
The challenge is to develop a curcumin with an increased bioavailability, with the aim of
reaching plasma concentrations that have demonstrated biological activity. In this purpose,
curcumin has been dissolved in oil and then absorbed into chylomicrons, to propose a surface-
controlled water-dispersible curcumin, with no modification of its structure [38, 39]. Curcu-
min was also co-administered with piperine, an inhibitor of hepatic and intestinal glucuronida-
tion [40] or included in a phosphatidylcholine phytosome complex [41, 42]. The clinical
relevance of these new formulations compared to the native curcumin should be demonstrated
in good clinical trials.
Altogether, these in vitro results indicate that the mixture COT might reduce inflammation
and pain in OA by reducing the synthesis of inflammatory and catabolic mediators by chon-
drocytes, probably by inhibiting NF-κB activation. These findings provide a preclinical basis
for the in vivo testing of the combinations and suggest that these natural compounds could be
helpful to alleviate symptoms in OA patients. These results support firstly the development
and use of the mixture COT as an anti-inflammatory / anti-osteoarthritic agent for treatment
of OA.
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